Loading...
•
Mar 31, 2021
ClearPoint Neuro Q1 2021 Earnings Report
Reported record revenue driven by growth across all business segments and a strong cash position following a public equity offering.
Key Takeaways
ClearPoint Neuro reported a strong first quarter with record revenue of $4.0 million, a 29% increase year-over-year. The company saw growth across all its business segments and ended the quarter with nearly $65.0 million in cash, bolstered by a successful public equity offering in February.
Total revenue increased by 29% to $4.0 million compared to the same period last year.
Functional neurosurgery navigation revenue increased by 10% to $1.9 million.
Biologics and drug delivery revenue increased by 61% to $1.7 million.
Capital equipment and software revenue increased by 31% to $0.5 million.
ClearPoint Neuro
ClearPoint Neuro
ClearPoint Neuro Revenue by Segment
Revenue by Segment
Biologics and Drug Delivery Revenue
CapyFin.com Forward Guidance
No specific forward guidance was provided in the press release.